Kombiglyze XR

Type: Product
Name: Kombiglyze XR
First reported Apr 25 2014 - Updated Apr 25 2014 - 1 reports

AstraZeneca net dips by 36% in Q1 to $506 million

AstraZeneca has posted dismal performance during the first quarter ended March 2014 and its net profit declined sharply by 36.4 per cent to $506 million from $1,012 million in the similar quarter of last year due to loss on disposal of Alderley Park and ... [Published PharmaBiz - Apr 25 2014]
First reported Apr 24 2014 - Updated Apr 24 2014 - 1 reports

Possible Link Between Heart Failure And Onglyza Diabetes Type 2 Drug Is Being Investigated By FDA, As Announced In February 2014

This Cardiovascular Side Effect Issue Also Involves Kombygilyze XR, A Saxagliptin - Metformin Combo Diabetes Medication (Posted by Tom Lamb at DrugInjuryWatch.com ) AstraZeneca's diabetes drugs Onglyza and Kombygilyze, both of which contain ... [Published Drug Injury Watch - Apr 24 2014]

Quotes

From the February 2014 "FDA Drug Safety Communication: FDA to review heart failure risk with diabetes drug saxagliptin (marketed as Onglyza and Kombiglyze XR)" Safety Announcement:
AstraZeneca CEO Pascal Soriot said, "Under a single leadership, we will maximise the potential of our innovative portfolio of non-insulin anti-diabetic medicines, bringing fresh momentum to our growth ambitions for this franchise." On completion of the deal, AstraZeneca paid BMS $2.7bn of initial consideration and has also agreed to pay upup to $1...
AstraZeneca chief executive officer Pascal Soriot said, "Together with Bristol-Myers Squibb we concluded that consolidating ownership of the diabetes portfolio would benefit both companies and allow us to better serve the needs of diabetic patients." Image: AstraZeneca is acquiring stake in Bristol-Myers Squibb's diabetes alliance for $4.1bn. Photo: Bristol-Myers Squibb Latest News
...the plaintiffs and defendants update the judge on the progress of the litigation and any problems that have developed," said Resource4thePeople. "We will monitor these developments and continue to update consumers who are following this litigation or are considering seeking compensation in connection with these allegations." The latest figures*** provided by the U S Judicial Panel for Multidistrict Litigation shows that there are now 163 cases in the multidistrict litigation...

More Content

All (22) | News (10) | Reports (0) | Blogs (12) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
AstraZeneca net dips by 36% in Q1 to $506 million [Published PharmaBiz - Apr 25 2014]
Possible Link Between Heart Failure And Onglyza... [Published Drug Injury Watch - Apr 24 2014]
AstraZeneca diabetes pen injector OK'd [Published News Leader - Mar 14 2014]
Januvia Pancreatic Cancer Allegations Help: Res... [Published PRWeb - Feb 27 2014]
As Byetta Lawsuits Move Forward, Bernstein Lieb... [Published PRWeb - Feb 13 2014]
AstraZeneca completes acquisition of Bristol-My... [Published Pharmaceutical Business Review - Feb 04 2014]
AstraZeneca Completes Acquisition of Diabetes A... [Published EON Transportation - Feb 03 2014]
AstraZeneca Completes Acquisition of Diabetes A... [Published EON Environment - Feb 03 2014]
AstraZeneca Completes Acquisition of Diabetes A... [Published EON Retail - Feb 03 2014]
AstraZeneca Completes Acquisition of Diabetes A... [Published EON Manufacturing - Feb 03 2014]
AstraZeneca Completes Acquisition of Diabetes A... [Published EON Science - Feb 03 2014]
AstraZeneca Completes Acquisition of Diabetes A... [Published EON: Enhanced Online News - Feb 03 2014]
AstraZeneca Completes Acquisition of Diabetes A... [Published EON Energy - Feb 03 2014]
AstraZeneca Completes Acquisition of Diabetes A... [Published EON Communications - Feb 03 2014]
AstraZeneca Completes Acquisition of Diabetes A... [Published EON Consumer - Feb 03 2014]
AstraZeneca Completes Acquisition of Diabetes A... [Published EON Business - Feb 03 2014]
AstraZeneca Completes Acquisition of Diabetes A... [Published Business Wire Health News - Feb 03 2014]
Januvia Pancreatic Cancer Allegations Alert: Re... [Published PRWeb - Jan 19 2014]
AstraZeneca to buy stake in Bristol-Myers Squib... [Published Pharmaceutical Business Review - Dec 20 2013]
AstraZeneca to buy Bristol-Myers' entire global... [Published PharmaBiz - Dec 19 2013]
Byetta Pancreatic Cancer Allegations Attorneys:... [Published PRWeb - Dec 19 2013]
AZ to acquire BMS share of diabetes assets [Published TrustNet - Dec 19 2013]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Possible Link Between Heart Failure And Onglyza... [Published Drug Injury Watch - Apr 24 2014]
This Cardiovascular Side Effect Issue Also Involves Kombygilyze XR, A Saxagliptin - Metformin Combo Diabetes Medication (Posted by Tom Lamb at DrugInjuryWatch.com ) AstraZeneca's diabetes drugs Onglyza and Kombygilyze, both of which contain ...
AstraZeneca Completes Acquisition of Diabetes A... [Published EON Transportation - Feb 03 2014]
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE: AZN) today announced that on February 1, 2014, it completed its acquisition of the entirety of Bristol-Myers Squibb’s interests in the companies’ diabetes alliance. The acquisition gives AstraZeneca ...
AstraZeneca Completes Acquisition of Diabetes A... [Published EON Environment - Feb 03 2014]
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE: AZN) today announced that on February 1, 2014, it completed its acquisition of the entirety of Bristol-Myers Squibb’s interests in the companies’ diabetes alliance. The acquisition gives AstraZeneca ...
AstraZeneca Completes Acquisition of Diabetes A... [Published EON Retail - Feb 03 2014]
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE: AZN) today announced that on February 1, 2014, it completed its acquisition of the entirety of Bristol-Myers Squibb’s interests in the companies’ diabetes alliance. The acquisition gives AstraZeneca ...
AstraZeneca Completes Acquisition of Diabetes A... [Published EON Manufacturing - Feb 03 2014]
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE: AZN) today announced that on February 1, 2014, it completed its acquisition of the entirety of Bristol-Myers Squibb’s interests in the companies’ diabetes alliance. The acquisition gives AstraZeneca ...
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.